Innovent Receives NMPA Breakthrough Designation for IBI310, the Anti-CTLA-4 Monoclonal Antibody, Combined with Sintilimab in Advanced Cervical Cancer Treatment – QNT Press Release5 years ago
Montreal insurtech Emma closes $6M Series A round, solidifying its place as a leader in the Canadian insurtech industry – QNT Press Release5 years ago
XP Inc. Files Its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2021 – QNT Press Release5 years ago
Crawford United Corporation Announces Fourth Quarter and Full Year 2021 Results – QNT Press Release5 years ago
